SBRA 📈 Sabra Healthcare REIT - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US78573L1061
SBRA: Nursing Homes, Senior Housing, Behavioral Health facilities, Specialty Hospitals
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities ('Senior Housing - Leased'), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements ('Senior Housing - Managed'), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada. Web URL: https://www.sabrahealth.com
Additional Sources for SBRA Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SBRA Stock Overview
| Market Cap in USD | 4,110m |
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
| GiC Sub-Industry | Health Care REITs |
| IPO / Inception | 2002-04-02 |
SBRA Stock Ratings
| Growth 5y | 34.7% |
| Fundamental | 15.8% |
| Dividend | 45.8% |
| Rel. Strength Industry | 701 |
| Analysts | 4.14/5 |
| Fair Price Momentum | 17.78 USD |
| Fair Price DCF | 34.40 USD |
SBRA Dividends
| Dividend Yield 12m | 7.08% |
| Yield on Cost 5y | 8.70% |
| Annual Growth 5y | -7.79% |
| Payout Consistency | 90.9% |
SBRA Growth Ratios
| Growth Correlation 3m | -11.1% |
| Growth Correlation 12m | 93.6% |
| Growth Correlation 5y | 41.2% |
| CAGR 5y | 4.20% |
| CAGR/Mean DD 5y | 0.20 |
| Sharpe Ratio 12m | 0.96 |
| Alpha | -7.51 |
| Beta | 1.38 |
| Volatility | 35.96% |
| Current Volume | 5428.3k |
| Average Volume 20d | 2290.7k |
What is the price of SBRA stocks?
As of December 21, 2024, the stock is trading at USD 16.96 with a total of 5,428,307 shares traded.
Over the past week, the price has changed by -3.68%, over one month by -9.91%, over three months by -7.35% and over the past year by +25.97%.
As of December 21, 2024, the stock is trading at USD 16.96 with a total of 5,428,307 shares traded.
Over the past week, the price has changed by -3.68%, over one month by -9.91%, over three months by -7.35% and over the past year by +25.97%.
Is Sabra Healthcare REIT a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Sabra Healthcare REIT is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.79 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SBRA as of December 2024 is 17.78. This means that SBRA is currently overvalued and has a potential downside of 4.83%.
Neither. Based on ValueRay Fundamental Analyses, Sabra Healthcare REIT is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.79 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SBRA as of December 2024 is 17.78. This means that SBRA is currently overvalued and has a potential downside of 4.83%.
Is SBRA a buy, sell or hold?
Sabra Healthcare REIT has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy SBRA.
Sabra Healthcare REIT has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy SBRA.
- Strong Buy: 8
- Buy: 0
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecast for SBRA stock price target?
According to ValueRays Forecast Model, SBRA Sabra Healthcare REIT will be worth about 19.2 in December 2025. The stock is currently trading at 16.96. This means that the stock has a potential upside of +13.33%.
According to ValueRays Forecast Model, SBRA Sabra Healthcare REIT will be worth about 19.2 in December 2025. The stock is currently trading at 16.96. This means that the stock has a potential upside of +13.33%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 20 | 17.9% |
| Analysts Target Price | 14.6 | -13.7% |
| ValueRay Target Price | 19.2 | 13.3% |